AAAAAA

   
Results: 1-7 |
Results: 7
HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE (EC) VS CYCLOPHOSPHAMIDE, METHOTREXATE, FLUOROURACIL (CMF) AS ADJUVANT CHEMOTHERAPY IN HIGH-RISK PREMENOPAUSAL BREAST-CANCER PATIENTS (PTS) - A PROSPECTIVE RANDOMIZED TRIAL
Authors: GALLIGIONI E CETTO G NASCIMBEN O BUONADAONA A CRIVELLARI D MOLINO A VERONESI A GRAIFF C BARNI S PUCCETTI C FERRAZZI E RECALDIN E SAVA C SARACCHINI S SACCO C
Citation: E. Galligioni et al., HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE (EC) VS CYCLOPHOSPHAMIDE, METHOTREXATE, FLUOROURACIL (CMF) AS ADJUVANT CHEMOTHERAPY IN HIGH-RISK PREMENOPAUSAL BREAST-CANCER PATIENTS (PTS) - A PROSPECTIVE RANDOMIZED TRIAL, European journal of cancer, 34, 1998, pp. 84-84
MITOXANTRONE (MX), 5-FLUOROURACIL (5-FU) AND HIGH-DOSE LEVO-FOLINIC ACID (HD-LFA) IN WIDELY METASTATIC HORMONE-REFRACTORY PROSTATE-CANCER (HRPC)
Authors: MAGAROTTO R NASCIMBEN O CIRILLO M PICECE V MOLON A PASTORELLO M BIASON R RECALDIN E
Citation: R. Magarotto et al., MITOXANTRONE (MX), 5-FLUOROURACIL (5-FU) AND HIGH-DOSE LEVO-FOLINIC ACID (HD-LFA) IN WIDELY METASTATIC HORMONE-REFRACTORY PROSTATE-CANCER (HRPC), Annals of oncology, 9, 1998, pp. 168-168
PROGNOSTIC-SIGNIFICANCE OF ESTROGEN-RECEPTORS IN 405 PRIMARY BREAST CANCERS - A COMPARISON OF IMMUNOHISTOCHEMICAL AND BIOCHEMICAL METHODS
Authors: MOLINO A MICCIOLO R TURAZZA M BONETTI F PIUBELLO Q CORGNATI A SPEROTTO L RECALDIN E SPAGNOLLI P MANFRIN E BONETTI A NORTILLI R TOMEZZOLI A POLLINI GP MODENA S CETTO GL
Citation: A. Molino et al., PROGNOSTIC-SIGNIFICANCE OF ESTROGEN-RECEPTORS IN 405 PRIMARY BREAST CANCERS - A COMPARISON OF IMMUNOHISTOCHEMICAL AND BIOCHEMICAL METHODS, Breast cancer research and treatment, 45(3), 1997, pp. 241-249
PROGNOSTIC-SIGNIFICANCE OF ESTROGEN-RECEPTORS IN 405 PRIMARY BREAST CANCERS (BC) - A COMPARISON OF IMMUNOHISTOCHEMICAL (ICA) AND BIOCHEMICAL (DCC) METHODS
Authors: MOLINO A TURAZZA M BONETTI F PIUBELLO Q CORGNATI A SPEROTTO L RECALDIN E SPAGNOLLI P MANFRIN E BONETTI A NORTILLI R TOMEZZOLI A POLLINI GP MODENA S CETTO GL MICCIOLO R
Citation: A. Molino et al., PROGNOSTIC-SIGNIFICANCE OF ESTROGEN-RECEPTORS IN 405 PRIMARY BREAST CANCERS (BC) - A COMPARISON OF IMMUNOHISTOCHEMICAL (ICA) AND BIOCHEMICAL (DCC) METHODS, European journal of cancer, 31A, 1995, pp. 690-690
ONDANSETRON VERSUS GRANISETRON, BOTH COMBINED WITH DEXAMETHASONE, IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS
Authors: BASURTO C CICCARESE G PALLADINO MA PICCIAFUOCO M RICCI S ANTONUZZO A ALLEGRINI G CONTE PF COGNETTI F CIRULLI S COLELLA E MILELLA M SAVARESE A STANI S CONTU A OLMEO N PIRO S PIRAS M PILO L PILO P NUZZO A URSINI LA TARABORRELLI M MELENA S BASILICO L BUZZI F BRUGIA M TRIPPA F DELRIO S TAGLIAVENTI M PICECE V CASSANDRINI P CIRILLO M MAGAROTTO R RECALDIN E CLERICO M BARTETTO O MORANDINI MP BAINOTTI L BONI C MORETTI G SAVOLDI L TATEO S CHIAPPARINI I ZARA C CATALANO G CASCINU S ALESSANDRONI P MASSIDDA B IONTA MT PEDDITZI E MONTINARI F CASARTELLI C MANDELLI D ROTONDO SG LELLI G CILENTI G MORRITTI M PUSCEDDU G SALARIS G PRESTI ML FAVALLI G GAMBINO A RAVELLI V CORTESI E GIOACCHINI N OLIVA A DAZZI C MONTANARI L CRUCIANI G DEMARINIS F SCARFONE G BOLIS MC SCAGLIOTTI G SELVAGGI G DONATI D MALACARNE P SANTORO A PARRA HS LOCATELLI MC LUPORINI G SANSONI E MATERA G FAVA C
Citation: C. Basurto et al., ONDANSETRON VERSUS GRANISETRON, BOTH COMBINED WITH DEXAMETHASONE, IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS, Annals of oncology, 6(8), 1995, pp. 805-810
DETECTION AT DIAGNOSIS OF TUMOR-CELLS IN BONE-MARROW ASPIRATES OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC) AND CLINICAL CORRELATIONS
Authors: PASINI F PELOSI G MOSTACCI R SANTO A MASOTTI A SPAGNOLLI P RECALDIN E CETTO GL
Citation: F. Pasini et al., DETECTION AT DIAGNOSIS OF TUMOR-CELLS IN BONE-MARROW ASPIRATES OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC) AND CLINICAL CORRELATIONS, Annals of oncology, 6(1), 1995, pp. 86-88
CISPLATIN PHARMACOKINETICS IN ELDERLY PATIENTS
Authors: BONETTI A FRANCESCHI T APOSTOLI P CETTO GL RECALDIN E MOLINO A LEONE R
Citation: A. Bonetti et al., CISPLATIN PHARMACOKINETICS IN ELDERLY PATIENTS, Therapeutic drug monitoring, 16(5), 1994, pp. 477-482
Risultati: 1-7 |